Free Trial
→ Stranded On The Flood Plains of History (From Porter & Company) (Ad)tc pixel Free EBS Stock Alerts

Emergent Biosolutions (EBS) Short Interest Ratio & Short Volume

Emergent Biosolutions logo
$8.24 +0.29 (+3.69%)
Closing price 03:59 PM Eastern
Extended Trading
$8.09 -0.15 (-1.86%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Emergent Biosolutions Short Interest Overview

As of May 29, 2026, Emergent Biosolutions (EBS) had a short interest of 9.76 million shares sold short, representing 20.12% of the public float. This marks a 1.63% increase in short interest since the prior report. The short interest ratio (days to cover) is 11.5, meaning it would take 11.5 days of the average trading volume of 753,789 shares to cover all short positions.

Current Short Interest
9,760,594 shares
Previous Short Interest
9,604,080 shares
Change Vs. Previous Month
1.63%
Dollar Volume Sold Short
$88.98 million
Short Interest Ratio
11.5 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
51,600,000 shares
Short Percent of Float
20.12%
Today's Trading Volume
780,411 shares
Average Trading Volume
753,789 shares
Today's Volume Vs. Average
104%
Short Selling Emergent Biosolutions?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Emergent Biosolutions and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

EBS Short Interest Over Time

EBS Days to Cover Over Time

EBS Percentage of Float Shorted Over Time

Emergent Biosolutions Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/20269,760,594 shares $88.98 million +1.6%20.1%11.5 $9.12
5/15/20269,604,080 shares $76.40 million -1.8%19.8%11.99 $7.96
4/30/20269,775,531 shares $81.19 million +1.4%20.1%18.42 $8.31
4/15/20269,643,974 shares $83.37 million -0.1%19.9%13.53 $8.65
3/31/20269,650,911 shares $80.06 million +8.7%19.9%11.29 $8.30
3/13/20268,875,813 shares $71.49 million -1.2%17.5%7.37 $8.06
2/27/20268,986,187 shares $73.57 million +1.3%17.7%7.67 $8.19
2/13/20268,870,355 shares $96.25 million +2.9%17.4%13.66 $10.85
1/30/20268,622,131 shares $97.73 million -2.2%17.0%9.83 $11.34
1/15/20268,818,514 shares $96.78 million -3.4%17.3%8.41 $10.98
12/31/20259,124,412 shares $112.69 million +1.2%17.9%12.15 $12.35
12/15/20259,020,934 shares $111.44 million +1.2%17.7%10.42 $12.35
11/28/20258,917,402 shares $99.61 million -3.7%17.5%10.86 $11.17
11/14/20259,260,505 shares $93.59 million +12.7%17.6%7.55 $10.11
10/31/20258,220,839 shares $102.22 million -6.9%15.6%5.17 $12.43
10/15/20258,830,000 shares $84.98 million -8.1%17.2%8 $9.62
9/30/20259,610,000 shares $84.66 million +8.5%18.8%8.4 $8.81
9/15/20258,860,000 shares $70.70 million +1.7%17.4%7 $7.98
8/31/20258,710,000 shares $72.16 million -11.3%17.1%6.8 $8.29
8/15/20259,820,000 shares $86.91 million -1.3%19.2%7.7 $8.85
7/31/20259,950,000 shares $58.44 million +9.8%19.5%7.2 $5.87
7/15/20259,060,000 shares $62.86 million -9.5%17.5%7.2 $6.94
6/30/202510,010,000 shares $63.86 million +25.3%19.3%7.9 $6.38
6/15/20257,990,000 shares $50.06 million +2.0%15.4%6.6 $6.27
5/31/20257,830,000 shares $49.68 million -1.0%15.1%6.4 $6.35
5/15/20257,910,000 shares $43.58 million +2.1%15.2%5.9 $5.51
4/30/20257,750,000 shares $41.31 million -14.1%14.9%6 $5.33
4/15/20259,020,000 shares $41.70 million +0.6%17.2%7.4 $4.62
3/31/20258,970,000 shares $43.53 million -2.1%17.1%7.4 $4.85
3/15/20259,160,000 shares $52.53 million +12.5%17.5%7.8 $5.74
2/28/20258,140,000 shares $60.68 million +14.8%15.4%7.1 $7.46
2/15/20257,090,000 shares $68.74 million +2.3%13.4%6.8 $9.70
1/31/20256,930,000 shares $78.63 million -1.6%13.1%5.8 $11.35
1/15/20257,040,000 shares $66.60 million -1.3%13.4%5.6 $9.46
12/31/20247,130,000 shares $68.16 million +2.7%13.5%5.6 $9.56
12/15/20246,940,000 shares $58.85 million +0.1%13.3%4.6 $8.48
11/30/20246,930,000 shares $70.13 million +1.8%13.3%4.3 $10.12
11/15/20246,810,000 shares $52.57 million -2.0%13.1%3.6 $7.72
10/31/20246,950,000 shares $62.90 million -10.8%13.4%2.9 $9.05
10/15/20247,790,000 shares $71.59 million -5.4%15.0%2.8 $9.19
I was right about SpaceX (Ad)

Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel

See how to claim your stake in SpaceX before the public can
9/30/20248,230,000 shares $68.64 million +84.1%15.9%2.7 $8.34
9/15/20244,470,000 shares $35.18 million +16.4%8.6%1.4 $7.87
8/31/20243,840,000 shares $31.91 million +11.0%7.6%1.2 $8.31
8/15/20243,460,000 shares $29.96 million -6.2%6.8%1.1 $8.66
7/31/20243,690,000 shares $46.90 million -19.1%7.3%1.3 $12.71
7/15/20244,560,000 shares $51.60 million -12.1%9.1%0.9 $11.32
6/30/20245,190,000 shares $35.40 million -18.0%10.3%1.1 $6.82
6/15/20246,330,000 shares $39.06 million +6.6%12.6%1.4 $6.17
5/31/20245,940,000 shares $33.86 million -1.7%11.8%1.3 $5.70
5/15/20246,040,000 shares $34.58 million -15.3%12.0%1.3 $5.73
4/30/20247,130,000 shares $13.40 million +21.1%14.1%1.2 $1.88
4/15/20245,890,000 shares $11.63 million +3.3%11.8%2 $1.98
3/31/20245,700,000 shares $14.42 million +16.1%11.4%1.9 $2.53
3/15/20244,910,000 shares $12.00 million -20.8%9.8%1.6 $2.45
2/29/20246,200,000 shares $19.96 million -46.3%12.5%2.1 $3.22
2/15/202411,540,000 shares $19.68 million +10.5%23.2%4.2 $1.71
1/31/202410,440,000 shares $17.43 million -11.7%21.0%7.8 $1.67
1/15/202411,820,000 shares $24.23 million +1.3%23.8%8.6 $2.05
12/31/202311,670,000 shares $28.01 million +3.0%23.5%8.4 $2.40
12/15/202311,330,000 shares $26.85 million +0.8%22.8%7.8 $2.37
11/30/202311,240,000 shares $24.05 million +4.3%22.6%6.6 $2.14
11/15/202310,780,000 shares $23.82 million -1.4%21.7%5.1 $2.21
10/31/202310,930,000 shares $22.84 million +21.9%22.0%4.7 $2.09
10/15/20238,970,000 shares $22.60 million +14.1%18.1%3.7 $2.52
9/30/20237,860,000 shares $26.72 million -16.9%15.8%3.3 $3.40
9/15/20239,460,000 shares $37.27 million +12.8%19.0%4 $3.94
8/31/20238,390,000 shares $39.35 million -9.3%16.8%3.9 $4.69
8/15/20239,250,000 shares $48.01 million +5.4%18.6%5.6 $5.19
7/31/20238,780,000 shares $60.36 million +5.0%18.1%5.8 $6.88
7/15/20238,360,000 shares $60.28 million +8.3%17.2%6.2 $7.21
6/30/20237,720,000 shares $56.66 million +9.8%15.9%5.3 $7.34
6/15/20237,030,000 shares $56.91 million +3.7%16.2%3.9 $8.10
5/31/20236,780,000 shares $57.83 million +6.8%15.5%3.9 $8.53
5/15/20236,350,000 shares $58.99 million -4.5%14.4%3.4 $9.29
4/30/20236,650,000 shares $58.72 million -7.5%15.1%3.7 $8.83
4/15/20237,190,000 shares $85.20 million -5.4%17.7%4.2 $11.85
3/31/20237,600,000 shares $78.74 million +22.4%18.7%4.6 $10.36
3/15/20236,210,000 shares $59.93 million +11.7%15.3%5.5 $9.65
2/28/20235,560,000 shares $68.83 million -1.1%13.7%5.1 $12.38
2/15/20235,620,000 shares $83.85 million No Change13.9%5.6 $14.92
1/31/20235,620,000 shares $74.13 million +4.9%13.9%5.7 $13.19
1/15/20235,360,000 shares $71.98 million -3.8%13.2%5.4 $13.43
12/30/20225,570,000 shares $65.78 million +63.3%13.7%5.8 $11.81
12/15/20223,410,000 shares $37.99 million +45.7%8.4%3.7 $11.14
11/30/20222,340,000 shares $28.78 million -9.0%5.7%2.9 $12.30
11/15/20222,570,000 shares $34.21 million +19.0%6.3%3.4 $13.31
10/31/20222,160,000 shares $45.06 million +6.4%5.3%3.4 $20.86
10/15/20222,030,000 shares $39.44 million -9.4%5.0%3.1 $19.43
9/30/20222,240,000 shares $47.02 million +9.3%5.5%3.4 $20.99
9/15/20222,050,000 shares $47.27 million +5.1%5.0%3.3 $23.06
Musk is burning $2.5 billion a quarter on AI. One company holds the key. (Ad)

SpaceX's S-1 filing reveals $7.7 billion spent on AI infrastructure in a single quarter - not chips, not software, but power infrastructure. The filing shows $23.85 billion in servers and $14 billion in construction in progress, all dependent on one company's hardware. Without this supplier, Colossus doesn't run and the $1.25 billion Anthropic pays monthly stops flowing. The stock is still trading like no one has read the filing - but analyst Dylan Jovine has, and he's releasing the name at no cost.tc pixel

Read the S-1 breakdown and get the company name free
8/31/20221,950,000 shares $46.84 million -34.8%4.8%3.1 $24.02
8/15/20222,990,000 shares $91.20 million -15.3%7.3%4.2 $30.50
7/31/20223,530,000 shares $122.28 million +2.6%8.6%4.7 $34.64
7/15/20223,440,000 shares $105.02 million +6.2%8.1%4.6 $30.53
6/30/20223,240,000 shares $100.57 million -3.6%7.6%4.4 $31.04
6/15/20223,360,000 shares $95.42 million -10.2%7.9%4.5 $28.40
5/31/20223,740,000 shares $123.27 million +12.0%9.1%4.9 $32.96
5/15/20223,340,000 shares $95.99 million -8.7%8.1%4.6 $28.74
4/30/20223,660,000 shares $118.51 million +13.3%8.9%6 $32.38
4/15/20223,230,000 shares $133.72 million +6.6%7.8%5.7 $41.40
3/31/20223,030,000 shares $124.41 million -8.5%7.3%5.2 $41.06
3/15/20223,310,000 shares $126.48 million -16.0%8.0%5.5 $38.21
2/28/20223,940,000 shares $163.04 million -5.1%9.3%5.9 $41.38
2/15/20224,150,000 shares $186.04 million +12.2%9.2%4.8 $44.83
1/31/20223,700,000 shares $173.16 million +5.4%8.2%4 $46.80
1/15/20223,510,000 shares $183.29 million +5.4%7.8%3.4 $52.22
12/31/20213,330,000 shares $144.76 million +21.5%7.4%3.4 $43.47
12/15/20212,740,000 shares $115.87 million +3.4%6.1%2.9 $42.29
11/30/20212,650,000 shares $116.92 million +63.6%5.5%3.2 $44.12
11/15/20211,620,000 shares $61.41 million -47.1%3.3%2.6 $37.91
10/29/20213,060,000 shares $145.87 million -4.7%6.3%5.8 $47.67
10/15/20213,210,000 shares $162.71 million -1.8%6.6%8.2 $50.69
9/30/20213,270,000 shares $163.73 million +2.2%6.8%7.9 $50.07
9/15/20213,200,000 shares $182.88 million -3.9%6.6%6.8 $57.15
8/31/20213,330,000 shares $210.06 million -5.9%6.9%6.4 $63.08
8/13/20213,540,000 shares $217.99 million -4.8%7.3%6.1 $61.58
7/30/20213,720,000 shares $245.15 million -0.5%7.7%5.9 $65.90
7/15/20213,740,000 shares $226.01 million +4.5%7.8%5.5 $60.43
6/30/20213,580,000 shares $225.50 million +20.5%7.4%4.5 $62.99
6/15/20212,970,000 shares $182.86 million +8.4%6.2%3.6 $61.57

EBS Short Interest - Frequently Asked Questions

Short interest is the volume of Emergent Biosolutions shares that have been sold short but have not yet been covered or closed out. As of May 29th, traders have sold 9,760,594 shares of EBS short. 20.12% of Emergent Biosolutions' shares are currently sold short. Learn More on Emergent Biosolutions' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EBS shares currently have a short interest ratio of 11.5. Learn More on Emergent Biosolutions's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.12% of Emergent Biosolutions' floating shares are currently sold short.

Emergent Biosolutions saw a increase in short interest during the month of May. As of May 29th, there was short interest totaling 9,760,594 shares, an increase of 1.6% from the previous total of 9,604,080 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

20.12% of Emergent Biosolutions' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Emergent Biosolutions: Johnson & Johnson (0.97%), Novavax, Inc. (28.41%), Innoviva, Inc. (8.10%), MannKind Corporation (10.08%), Zenas BioPharma, Inc. (22.09%), OPKO Health, Inc. (8.70%), Lexicon Pharmaceuticals, Inc. (6.86%), Geron Corporation (11.38%), Ironwood Pharmaceuticals, Inc. (10.16%), Crescent Biopharma, Inc. (12.95%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling EBS is an investing strategy that aims to generate trading profit from Emergent Biosolutions as its price is falling. EBS shares are trading up $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Emergent Biosolutions occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EBS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EBS, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like EBS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:EBS) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Forbes calls this a "golden era" for retirement income
Forbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Live demo of Elon Musk’s AI agent
Jeff Brown picked Nvidia in 2016 - it's up 25,155%. He recommended Bitcoin at $240 - it's up 31,219%. Now he's...
Brownstone Research | Sponsoredtc pixel
No. You’re not imagining it…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel